السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin mylan 1000 mg filmdragerad tablett
mylan ab - metforminhydroklorid - filmdragerad tablett - 1000 mg - metforminhydroklorid 1000 mg aktiv substans - metformin
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin vitabalans 1000 mg filmdragerad tablett
vitabalans oy - metforminhydroklorid - filmdragerad tablett - 1000 mg - metforminhydroklorid 1000 mg aktiv substans - metformin
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin teva 850 mg filmdragerad tablett
teva sweden ab - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin bluefish 850 mg filmdragerad tablett
bluefish pharmaceuticals ab - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin mylan 850 mg filmdragerad tablett
mylan ab - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin
الاتحاد الأوروبي -
السويدية -
EMA (European Medicines Agency)
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin aristo 1000 mg filmdragerad tablett
aristo pharma gmbh - metforminhydroklorid - filmdragerad tablett - 1000 mg - metforminhydroklorid 1000 mg aktiv substans - metformin
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin aristo 850 mg filmdragerad tablett
aristo pharma gmbh - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin aurobindo 1000 mg filmdragerad tablett
aurobindo pharma (malta) limited - metforminhydroklorid - filmdragerad tablett - 1000 mg - metforminhydroklorid 1000 mg aktiv substans - metformin
السويد -
السويدية -
Läkemedelsverket (Medical Products Agency)
metformin aurobindo 850 mg filmdragerad tablett
aurobindo pharma (malta) limited - metforminhydroklorid - filmdragerad tablett - 850 mg - metforminhydroklorid 850 mg aktiv substans - metformin